Non-AIDS defining cancer (NADC) among HIV-infected patients at an oncology tertiary-care center in Mexico.

Abstract:

BACKGROUND:Non-AIDS defining cancers (NADCs) have been an increasing cause of morbidity and mortality in patients with HIV. There is no data on the spectrum of NADCs in Mexico. We describe the type of neoplasms, clinical characteristics, and outcomes of HIV-infected patients with NADCs. METHODS:We conducted a retrospective study of all patients with confirmed diagnosis of NADC attending the HIV/AIDS clinic at the National Cancer Institute in Mexico City (a tertiary-care center for adult patients with cancer) from January 1990 to December 2016. RESULTS:From 1126 HIV-positive individuals seen at the institute since 1990, 127 (11.3%) were diagnosed with NADCs; seven patients developed two NADCs during their follow-up. At diagnosis of NADC median age was 43.7 ± 10.9 years; 101 (79.5%) were male; median CD4 was 273 cells/mm3, 70 patients had a CD4 count of > 200 cells/mm3, 73 had undetectable HIV viral load and 82 had taken combined antiretroviral therapy (cART) for more than 1 year. The most frequent NADCs were in men, Hodgkin lymphoma (34.3%) followed by anal cancer (15.7%), whereas in women, were vulvo-vaginal cancers associated to human papilloma virus (HPV) (51.8%), followed by breast cancer (25.9%). The main risk factor associated with death was cancer progression or relapse (OR, 28.2, 2.5-317.1; p = 0.007). CONCLUSIONS:HL- and HPV-related neoplasms are the commonest NADC in a cancer referral hospital from a middle-income country with universal access to cART since year 2005. Screening for early anogenital lesions should be emphasized in patients with HIV. It is essential to establish multidisciplinary groups involving Hemato-oncologists, Oncologists, Gynecologists, and HIV Specialists in the treatment of these patients.

journal_name

AIDS Res Ther

authors

Cornejo-Juárez P,Cavildo-Jerónimo D,Volkow-Fernández P

doi

10.1186/s12981-018-0202-2

subject

Has Abstract

pub_date

2018-10-27 00:00:00

pages

16

issue

1

issn

1742-6405

pii

10.1186/s12981-018-0202-2

journal_volume

15

pub_type

杂志文章
  • Validity assessment of the PROMIS fatigue domain among people living with HIV.

    abstract:PURPOSE:To evaluate psychometric characteristics and cross-sectional and longitudinal validity of the 7-item PROMIS® Fatigue Short Form and additional fatigue items among people living with HIV (PLWH) in a nationally distributed network of clinics collecting patient reported data at the time of routine clinical care. ...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/s12981-017-0146-y

    authors: Gibbons LE,Fredericksen R,Batey DS,Dant L,Edwards TC,Mayer KH,Mathews WC,Morales LS,Mugavero MJ,Yang FM,Paez E,Kitahata MM,Patrick DL,Crane HM,Crane PK,Centers for AIDS Research Network of Integrated Clinical Systems (CNICS

    更新日期:2017-04-11 00:00:00

  • Evasion of adaptive immunity by HIV through the action of host APOBEC3G/F enzymes.

    abstract::APOBEC3G (A3G) and APOBEC3F (A3F) are DNA-mutating enzymes expressed in T cells, dendritic cells and macrophages. A3G/F have been considered innate immune host factors, based on reports that they lethally mutate the HIV genome in vitro. In vivo, A3G/F effectiveness is limited by viral proteins, entrapment in inactive ...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章,评审

    doi:10.1186/s12981-017-0173-8

    authors: Grant M,Larijani M

    更新日期:2017-09-12 00:00:00

  • Renal function change after switching tenofovir disoproxil fumarate for tenofovir alafenamide in the HIV-positive patients of a metropolitan sexual health service.

    abstract:BACKGROUND:Tenofovir disoproxil fumarate (TDF) is widely used in the management of HIV-infection, but has been associated with renal impairment in a small proportion of patients. Tenofovir alafenamide (TAF), a novel prodrug of tenofovir, causes less renal impairment and can improve renal function in patients switched f...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/s12981-019-0256-9

    authors: Turner D,Drak D,O'Connor CC,Templeton DJ,Gracey DM

    更新日期:2019-12-07 00:00:00

  • Eradication of HIV-1 latent reservoirs through therapeutic vaccination.

    abstract::Despite the significant success of combination anti-retroviral therapy to reduce HIV viremia and save lives, HIV-1 infection remains a lifelong infection that must be appropriately managed. Advances in the understanding of the HIV infection process and insights from vaccine development in other biomedical fields such ...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章,评审

    doi:10.1186/s12981-017-0177-4

    authors: Pankrac J,Klein K,Mann JFS

    更新日期:2017-09-12 00:00:00

  • Post-exposure prophylaxis for SIV revisited: animal model for HIV prevention.

    abstract:BACKGROUND:A 4-week, uninterrupted treatment with 9-(2-phosphonyl-methoxypropyly)adenine (PMPA, commonly called tenofovir) completely prevents simian immunodeficiency virus (SIVmne) infection in cynomolgus macaques if treatment begins within 24 hours after SIVmne inoculation, but is less effective if treatment is delay...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/1742-6405-3-29

    authors: Emau P,Jiang Y,Agy MB,Tian B,Bekele G,Tsai CC

    更新日期:2006-11-28 00:00:00

  • Implementation of antiretroviral therapy (ART) in former Soviet Union countries.

    abstract::Against the current global trends, in the former Soviet Union (FSU) countries HIV prevalence is on the rise. Visa-free movement across borders has facilitated migrant-associated HIV transmission within this region. Despite efforts from the governments to curtail the growing epidemic, there is still a serious need for ...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章,评审

    doi:10.1186/s12981-019-0251-1

    authors: Amangaldiyeva A,Davlidova S,Baiserkin B,Dzissyuk N,DeHovitz J,Ali S

    更新日期:2019-11-19 00:00:00

  • Inhibition of highly productive HIV-1 infection in T cells, primary human macrophages, microglia, and astrocytes by Sargassum fusiforme.

    abstract:BACKGROUND:The high rate of HIV-1 mutation and increasing resistance to currently available antiretroviral (ART) therapies highlight the need for new antiviral agents. Products derived from natural sources have been shown to inhibit HIV-1 replication during various stages of the virus life cycle, and therefore represen...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/1742-6405-3-15

    authors: Paskaleva EE,Lin X,Li W,Cotter R,Klein MT,Roberge E,Yu EK,Clark B,Veille JC,Liu Y,Lee DY,Canki M

    更新日期:2006-05-25 00:00:00

  • HLA-B*57:01 screening and hypersensitivity reaction to abacavir between 1999 and 2016 in the OPERA® observational database: a cohort study.

    abstract:BACKGROUND:HLA-B*57:01 screening was added to clinical care guidelines in 2008 to reduce the risk of hypersensitivity reaction from abacavir. The uptake of HLA-B*57:01 screening and incidence of hypersensitivity reaction were assessed in a prospective clinical cohort in the United States to evaluate the effectiveness o...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/s12981-019-0217-3

    authors: Mounzer K,Hsu R,Fusco JS,Brunet L,Henegar CE,Vannappagari V,Stainsby CM,Shaefer MS,Ragone L,Fusco GP

    更新日期:2019-01-16 00:00:00

  • Morning free and total testosterone in HIV-infected men: implications for the assessment of hypogonadism.

    abstract:BACKGROUND:Hypogonadism is common among HIV-infected men, even among men receiving antiretroviral therapy (ART). Our objective in this study was to determine the prevalence of biochemical hypogonadism among HIV-infected men compared with HIV-uninfected controls. We also examined the use of free testosterone (FT) and to...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/1742-6405-11-6

    authors: Monroe AK,Dobs AS,Palella FJ,Kingsley LA,Witt MD,Brown TT

    更新日期:2014-01-22 00:00:00

  • Clade, Country and Region-specific HIV-1 Vaccines: Are they necessary?

    abstract::Today, scientists are often encouraged to custom-design vaccines based on a particular country or clade. Here, we review the scientific literature and then suggest that the overwhelming endeavor to produce a unique vaccine for every world region or virus subtype may not be necessary. ...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/1742-6405-2-3

    authors: Slobod KS,Coleclough C,Brown SA,Stambas J,Zhan X,Surman S,Jones BG,Zirkel A,Freiden PJ,Brown B,Sealy R,Bonsignori M,Hurwitz JL

    更新日期:2005-04-28 00:00:00

  • Sexual behavior of HIV-positive adults not accessing HIV treatment in Mombasa, Kenya: Defining their prevention needs.

    abstract:BACKGROUND:HIV spread continues at high rates from infected persons to their sexual partners. In 2009, an estimated 2.6 million new infections occurred globally. People living with HIV (PLHIV) receiving treatment are in contact with health workers and therefore exposed to prevention messages. By contrast, PLHIV not rec...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/1742-6405-9-9

    authors: Sarna A,Luchters S,Pickett M,Chersich M,Okal J,Geibel S,Kingola N,Temmerman M

    更新日期:2012-03-19 00:00:00

  • German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients.

    abstract:BACKGROUND:Current German and European HIV guidelines recommend early evaluation of HCV treatment in all HIV/HCV co-infected patients. However, there are still considerable barriers to initiate HCV therapy in everyday clinical practice. This study evaluates baseline characteristics, "intention-to-treat" pattern and out...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/1742-6405-11-16

    authors: Beisel C,Heuer M,Otto B,Jochum J,Schmiedel S,Hertling S,Degen O,Lüth S,van Lunzen J,Schulze Zur Wiesch J

    更新日期:2014-07-01 00:00:00

  • HIV sero-discordance among married HIV patients initiating anti-retroviral therapy in northern Vietnam.

    abstract:BACKGROUND:In many countries in Asia, the HIV epidemic is in a concentrated phase, with high prevalence in certain risk groups, such as men who inject drugs. There is also a rapid increase of HIV among women. The latter might be due to high levels of sero-discordant couples and increasing transmission from male to fema...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/s12981-016-0124-9

    authors: Van Tam V,Cuong DD,Alfven T,Phuc HD,Chuc NT,Hoa NP,Diwan V,Larsson M

    更新日期:2016-11-15 00:00:00

  • Estimating the impact of expanded access to antiretroviral therapy on maternal, paternal and double orphans in sub-Saharan Africa, 2009-2020.

    abstract:BACKGROUND:HIV/AIDS has orphaned 11.6 million children in sub-Saharan Africa. Expanded antiretroviral therapy (ART) use may reduce AIDS orphanhood by decreasing adult mortality and population-level HIV transmission. METHODS:We modeled two scenarios to measure the impact of adult ART use on the incidence of orphanhood ...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/1742-6405-8-13

    authors: Anema A,Au-Yeung CG,Joffres M,Kaida A,Vasarhelyi K,Kanters S,Montaner JS,Hogg RS

    更新日期:2011-03-07 00:00:00

  • Is the Sexual Behaviour of HIV Patients on Antiretroviral therapy safe or risky in Sub-Saharan Africa? Meta-Analysis and Meta-Regression.

    abstract:BACKGROUND:Reports on the sexual behavior of people on antiretroviral therapy (ART) are inconsistent. We selected 14 articles that compared the sexual behavior of people with and without ART for this analysis. METHODS:We included both cross-sectional studies that compared different ART-naïve and ART-experienced partic...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/1742-6405-9-14

    authors: Berhan A,Berhan Y

    更新日期:2012-05-14 00:00:00

  • HIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vector.

    abstract::BACKGROUND: RNA interference (RNAi) mediated by small interfering RNAs (siRNAs) has proved to be a highly effective gene silencing mechanism with great potential for HIV/AIDS gene therapy. Previous work with siRNAs against cellular coreceptors CXCR4 and CCR5 had shown that down regulation of these surface molecules co...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/1742-6405-2-1

    authors: Anderson J,Akkina R

    更新日期:2005-01-13 00:00:00

  • Decrease of vitamin D concentration in patients with HIV infection on a non nucleoside reverse transcriptase inhibitor-containing regimen.

    abstract:BACKGROUND:Vitamin D is an important determinant of bone health and also plays a major role in the regulation of the immune system. Interestingly, vitamin D status before the start of highly active antiretroviral therapy (HAART) has been recently associated with HIV disease progression and overall mortality in HIV-posi...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/1742-6405-7-40

    authors: Conesa-Botella A,Florence E,Lynen L,Colebunders R,Menten J,Moreno-Reyes R

    更新日期:2010-11-23 00:00:00

  • Therapeutic drug monitoring of voriconazole: a case report of multiple drug interactions in a patient with an increased CYP2C19 activity.

    abstract:BACKGROUND:Voriconazole is metabolized by cytochrome P450 (CYP) 2C19 and CYP 3A4. Drug-drug interactions and genetic polymorphisms modulate their activities. CASE PRESENTATION:A 35-year old African female patient with resistant HIV and a cerebral mass of unknown origin was treated with voriconazole for a suspicion of ...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/1742-6405-11-25

    authors: Bouatou Y,Samer CF,Ing Lorenzini KR,Daali Y,Daou S,Fathi M,Rebsamen M,Desmeules J,Calmy A,Escher M

    更新日期:2014-08-04 00:00:00

  • A placebo-controlled pilot study of intensification of antiretroviral therapy with mycophenolate mofetil.

    abstract:PURPOSE:We studied the safety, tolerability, virologic, and immunologic effects of mycophenolate mofetil (MMF) added to a stable antiretroviral therapy (ART) in the setting of low-level viremia. METHODS:MMF 500 mg BID or placebo was given to patients thought to be adherent on stable ART with plasma viremia between 200...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/1742-6405-3-16

    authors: Kaur R,Bedimo R,Kvanli MB,Turner D,Shaw L,Margolis D

    更新日期:2006-05-26 00:00:00

  • Plasma HIV-1 RNA viral load rebound among people who inject drugs receiving antiretroviral therapy (ART) in a Canadian setting: an ethno-epidemiological study.

    abstract:BACKGROUND:People who inject drugs (PWID) living with HIV often experience sub-optimal antiretroviral therapy (ART) treatment outcomes, including HIV plasma viral load (PVL) rebound. While previous studies have identified risk factors for PVL rebound among PWID, no study has examined the perspectives of PWID who have e...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/s12981-016-0108-9

    authors: Small W,Milloy MJ,McNeil R,Maher L,Kerr T

    更新日期:2016-07-25 00:00:00

  • Elevated risks of death for diabetes mellitus and cardiovascular diseases in Italian AIDS cases.

    abstract:: After the introduction of highly active antiretroviral therapies (HAART), an increased incidence of insulin resistance, diabetes mellitus (DM), and cardiovascular diseases has been described. The impact of such conditions on mortality in the post-HAART era has been also assessed in various modes in the literature. In...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/1742-6405-7-11

    authors: Serraino D,Bruzzone S,Zucchetto A,Suligoi B,De Paoli A,Pennazza S,Camoni L,Dal Maso L,De Paoli P,Rezza G

    更新日期:2010-05-24 00:00:00

  • Protease inhibitor associated mutations compromise the efficacy of therapy in human immunodeficiency virus-1 (HIV-1) infected pediatric patients: a cross-sectional study.

    abstract:BACKGROUND:Although the introduction of combined therapy with reverse transcriptase and protease inhibitors has resulted in considerable decrease in HIV related mortality; it has also induced the development of multiple drug-resistant HIV-1 variants. The few studies on HIV-1 mutagenesis in HIV infected children have no...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/1742-6405-4-15

    authors: Malhotra A,Gaur S,Whitley-Williams P,Loomis C,Petrova A

    更新日期:2007-07-09 00:00:00

  • HIV-1 Subtype distribution in morocco based on national sentinel surveillance data 2004-2005.

    abstract:BACKGROUND:Little is known about HIV-1 subtype distribution in Morocco. Some data suggest an emergence of new HIV subtypes. We conducted phylogenetic analysis on a nationally representative sample of 60 HIV-1 viral specimens collected during 2004-2005 through the Morocco national HIV sentinel surveillance survey. RESU...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/1742-6405-9-5

    authors: Akrim M,Lemrabet S,Elharti E,Gray RR,Tardy JC,Cook RL,Salemi M,Andre P,Azarian T,Aouad RE

    更新日期:2012-02-14 00:00:00

  • Anti-infective treatment in HIV-infected patients during perioperative period.

    abstract:UNLABELLED: OBJECTIVE:To investigate anti-infective treatments in HIV-infected surgical patients during the perioperative period. METHODS:A retrospective study of sepsis and surgical site infections (SSIs) was conducted in 266 HIV-infected patients. The patients were divided into 3 groups based on CD4+ T cells counts...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/1742-6405-9-36

    authors: Liu B,Zhang L,Guo R,Su J,Li L,Si Y

    更新日期:2012-11-27 00:00:00

  • HIV-associated adipose redistribution syndrome (HARS): definition, epidemiology and clinical impact.

    abstract::A segment of the HIV infected population develops abnormal and excessive accumulation of adipose tissue in the trunk, including accumulation of visceral (deep abdominal) adipose tissue. This condition, known as HIV-related adipose redistribution syndrome (HARS), may also be accompanied by fat accumulation in the upper...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/1742-6405-4-16

    authors: Lichtenstein K,Balasubramanyam A,Sekhar R,Freedland E

    更新日期:2007-07-16 00:00:00

  • Validation of a self-reported HIV symptoms list: the ISS-HIV symptoms scale.

    abstract:BACKGROUND:To describe the development and the psychometric properties of the Istituto Superiore di Sanità-HIV symptoms scale (lSS-HIV symptoms scale). METHODS:The ISS-HIV symptom scale was developed by an Italian working team including researchers, physicians and people living with HIV. The development process went t...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/s12981-016-0102-2

    authors: Bucciardini R,Pugliese K,Francisci D,Costantini A,Schiaroli E,Cognigni M,Tontini C,Lucattini S,Fucili L,Di Gregorio M,Mirra M,Fragola V,Pompili S,Murri R,Vella S

    更新日期:2016-04-09 00:00:00

  • Injection drug use and patterns of highly active antiretroviral therapy use: an analysis of ALIVE, WIHS, and MACS cohorts.

    abstract:BACKGROUND:Sustained use of antiretroviral therapy has been consistently shown to be one of the primary predictors of long-term effectiveness. Switching and discontinuation reflect patient and provider decisions that may limit future treatment options. In this study, we utilize data reported at semi-annual study visits...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/1742-6405-4-12

    authors: Morris JD,Golub ET,Mehta SH,Jacobson LP,Gange SJ

    更新日期:2007-06-06 00:00:00

  • Antiretroviral therapy at a district hospital in Ethiopia prevents death and tuberculosis in a cohort of HIV patients.

    abstract:BACKGROUND:Although highly active antiretroviral therapy (HAART) reduces mortality in the developed world, it remains undocumented in resource-poor settings. We assessed the effect of HAART on patient mortality and tuberculosis incidence rate under routine clinical care conditions in Ethiopia. The objective of this stu...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章

    doi:10.1186/1742-6405-3-10

    authors: Jerene D,Naess A,Lindtjørn B

    更新日期:2006-04-07 00:00:00

  • Stem cell transplantation in strategies for curing HIV/AIDS.

    abstract::HIV-1 can persist in a latent form in resting memory CD4+ cells and macrophages carrying an integrated copy of the HIV genome. Because of the presence of these stable reservoir cells, eradication by antiretroviral therapy is unlikely and in order to achieve eradication, alternative treatment options are required. Stem...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章,评审

    doi:10.1186/s12981-016-0114-y

    authors: Hütter G

    更新日期:2016-09-13 00:00:00

  • Bone mineral density in people living with HIV: a narrative review of the literature.

    abstract::Bone health status is largely absent in South Africa, the main reasons being the absence and cost-effectiveness of specific screening equipment for assessing bone mineral density (BMD). Various risk factors seem to play a role, some of which can be modified to change bone health status. Urbanisation is also a public h...

    journal_title:AIDS research and therapy

    pub_type: 杂志文章,评审

    doi:10.1186/s12981-017-0162-y

    authors: Kruger MJ,Nell TA

    更新日期:2017-07-26 00:00:00